Design synthesis and antibacterial activity studies of new thiadiazoloquinolone compounds
暂无分享,去创建一个
Jalal A. Zahra | Mohammed M. Abadleh | Raed A. Al‐Qawasmeh | P. Vicini | M. Incerti | F. Zani | Rabab Albashiti | M. El-Abadelah
[1] Hisashi Takahashi,et al. Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens. , 2013, Journal of medicinal chemistry.
[2] M. K. Kathiravan,et al. Topoisomerase as target for antibacterial and anticancer drug discovery , 2013, Journal of enzyme inhibition and medicinal chemistry.
[3] Rosaleen J. Anderson,et al. Quinolone Antibacterial Agents , 2012 .
[4] Jalal A. Zahra,et al. Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents. , 2011, Bioorganic & medicinal chemistry.
[5] Jalal A. Zahra,et al. Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents. , 2010, Bioorganic & medicinal chemistry.
[6] Jalal A. Zahra,et al. Synthesis and antibacterial activity of 9-cyclopropyl-4-fluoro-6-oxo- 6,9-dihydro-(1,2,5)thiadiazolo(3,4-h)quinoline-7-carboxylic acid and its ethyl ester , 2009 .
[7] L. Kamen,et al. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. , 2008, Current medical research and opinion.
[8] A. Wagman. 7.19 – Quinolone Antibacterial Agents , 2007 .
[9] A. Shafiee,et al. Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria. , 2006, Mini reviews in medicinal chemistry.
[10] D. J. Triggle,et al. Comprehensive medicinal chemistry II , 2006 .
[11] L. Mitscher. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. , 2005, Chemical reviews.
[12] A. Bryskier. Antimicrobial agents: antibacterials and antifungals. , 2005 .
[13] S. Paisley,et al. Clinical effectiveness of oral treatments for spasticity in multiple sclerosis: a systematic review , 2002, Multiple sclerosis.
[14] L. Mitscher,et al. The 2‐pyridone antibacterial agents: bacterial topoisomerase inhibitors , 2000, Medicinal research reviews.
[15] T. Gootz,et al. Chemistry and Mechanism of Action of the Quinolone Antibacterials , 2000 .
[16] H. Lamb,et al. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. , 2000, Drugs.
[17] A. Krebs,et al. The Synthesis and Biological Properties of 6-Fluoroquinolonecarboxylic Acids , 1997 .
[18] L. Heifets,et al. Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages , 1994, Antimicrobial Agents and Chemotherapy.
[19] M. Tashiro,et al. Sulfur Nitride in Organic Chemistry. Part 19. Selective Formation of Benzo- and Benzobis[1,2,5]thiadiazole Skeleton in the Reaction of Tetrasulfur Tetranitride with Naphthalenols and Related Compounds , 1991 .
[20] Hutchinson Dr. Modified release tizanidine: a review , 1989 .
[21] P. Fernandes,et al. Structure-activity relationships of the fluoroquinolones , 1989, Antimicrobial Agents and Chemotherapy.
[22] K. Grohe,et al. Cycloaracylierung von Enaminen, II. Synthese von 1-Amino-4-chinolon-3-carbonsäuren , 1987 .
[23] P. Fernandes,et al. Synthesis and structure-activity relationship of 1-aryl-6,8-difluoroquinolone antibacterial agents. , 1987, Journal of medicinal chemistry.
[24] P. Fernandes,et al. Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents. , 1985, Journal of medicinal chemistry.
[25] G. Ridgway,et al. Comparative in vitro studies with 4-quinolone antimicrobials. , 1985, Drugs under experimental and clinical research.
[26] K. Sharma,et al. Condensed Heterocycles; Xl. Synthesis of 1,2,5-Thia(selena)diazolo[3,4-b]quinolines and 1,2,5-Thia(selena)diazolo[3,4-h]quinolines , 1981 .
[27] R. Singh,et al. CONDENSED HETEROCYCLES; XI. SYNTHESIS OF 1,2,5-THIA(SELENA)DIAZOLO(3,4-B)QUINOLINES AND 1,2,5-THIA(SELENA)DIAZOLO(3,4-H)QUINOLINES , 1981 .
[28] H. Koga,et al. Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids. , 1980, Journal of medicinal chemistry.
[29] D. Klamann,et al. Über Pseudonitrosite, Nitroxime und Furoxane , 1965 .
[30] V. G. Pesin,et al. Behavior of 4- and 5-aminobenz-2,1,3-thiadiazoles under Herz and Skraup reaction conditions , 1965 .